MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202621088084 A) filed by Sundardas Raghunath Gore; and Seema Sundardas Gore on July 19, 2026, for Micro-Fenestrated Therapeutic Contact Lens System For Controlled Diffusion, Optical Modulation, And Corneal Interface Regulation.
Inventor includes Sundardas Raghunath Gore.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: ABSTRACT MICRO-FENESTRATED THERAPEUTIC CONTACT LENS SYSTEM FOR CONTROLLED DIFFUSION, OPTICAL MODULATION, AND CORNEAL INTERFACE REGULATION A micro-fenestrated therapeutic contact lens system for regulated diffusion and corneal interface control is disclosed. The system comprises a lens body formed of a biocompatible material, a central optical zone within the lens body configured for visual clarity and substantially free of micro-fenestrations, and a plurality of micro-fenestrations arranged in at least one peripheral or patterned therapeutic zone surrounding the central optical zone. The plurality of micro-fenestrations have predefined dimensional and spatial parameters configured to permit controlled diffusion of tear fluid, gases, and therapeutic agents between a pre-lens region and a post-lens region at the corneal interface. The micro-fenestrations are further configured such that eyelid blinking induces pulsatile micro-fluidic exchange through at least a subset of the micro-fenestrations, promoting renewal of post-lens tear fluid and reducing stagnation of exudate. The system is compatible with corneal cross-linking, drug delivery, keratoconus management, and ocular surface disease treatment. [
Disclaimer: Curated by HT Syndication.
